key: cord-0749367-uv8xqhlf
authors: Kumar, Kris; Vogt, Joshua C.; Divanji, Punag H.; Cigarroa, Joaquin E.
title: Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID‐19 infection
date: 2020-05-07
journal: Catheter Cardiovasc Interv
DOI: 10.1002/ccd.28960
sha: f519e29ab3ca6a280bae6c0cd84e003bf2cfa5c9
doc_id: 749367
cord_uid: uv8xqhlf

A 48‐year‐old woman with a past medical history of migraines and hyperlipidemia presented due to severe retrosternal chest pain with no other associated signs or symptoms. The patient was hemodynamically stable and was found to have an elevated troponin with electrocardiogram showing no ischemic changes. Computed tomography of the coronary arteries showed a left dominant system with dissection extending from the mid‐to‐distal left anterior descending (LAD) artery. The patient was subsequently discharged on medical therapy but returned 3 days later due to worsening chest pain. Electrocardiogram revealed inferior and anteroseptal ST segment changes with peak troponin of 14.9 ng/ml (reference range <0.80 ng/ml). Coronavirus disease 2019 (COVID‐19) nasopharyngeal swab was performed prior to urgent coronary angiogram. Coronary angiogram was performed with full personal protective equipment for respiratory and droplet precautions due to pending COVID‐19 testing results. Angiogram revealed spontaneous coronary artery dissection (SCAD) extending from the ostium of the LAD to the distal vessel. COVID‐19 testing returned positive while in intensive care unit. The patient was not a percutaneous coronary intervention candidate due to the extent of the dissection and was not a surgical candidate due to a lack of graftable target and medical management was continued. To our knowledge, this case is the first in which SCAD has been reported in the LAD in a patient with COVID‐19 with no other symptoms of respiratory illness or symptoms classically associated with the novel coronavirus. SCAD should be considered on the differential as one of the various cardiac manifestations of COVID‐19 infection.

Novel coronavirus disease 2019 (COVID-19) as a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the global pandemic that has infected over 1.5 million patients worldwide 1 with cardiac manifestations and injury in up to 20-28% of patients. 2, 3 While the exact mechanism of cardiac injury in this population is unknown, the proposed etiology is thought to be due to changes in myocardial demand as a result of infection leading to an ischemic cascade and increased inflammatory markers that predispose patients to plaque instability and subsequent rupture. 4 Patients with cardiovascular injury have a fourfold increased risk of mortality compared to those without cardiovascular disease. 3 Coronary disease and myocardial infarction have been noted to occur concomitantly in patients with influenza and respiratory illnesses on both presentation and in autopsy studies. 5,6 COVID-19 has been documented as a cause of heart failure, acute coronary syndromes, myocardial infarction, and myocarditis leading to lifethreatening arrhythmias. 7 Due to risk of transmission in both symptomatic and asymptomatic patients, protocols have been rapidly instituted in order to protect patients and healthcare workers to prevent further spread of disease. 8 We present a novel case of spontaneous coronary artery dissection (SCAD) in the left anterior descending (LAD) artery in a patient who was COVID-19 positive with no other symptoms of SARS-CoV-2 to help illustrate the wide range of cardiac manifestations that patients can present with and for clinicians to keep the novel coronavirus in their differential as the cause of new cardiac complications.

A 48-year-old woman with a past medical history of migraines and hyperlipidemia presented to the emergency room due to a 1-day history of severe chest pain that awoke her from sleep. She rated the pain as 9 out of 10 severity retrosternal tightness with radiation to her neck and bilateral arms. She was given aspirin 324 mg along with sublingual nitroglycerin for pain control with improvement in her symptoms. As recently as 1 day prior, she was exercising with no issues and had a functional capacity that exceeded 8 metabolic equivalents. She was afebrile without respiratory complaint. 

World Health Organization. Coronavirus disease (COVID-19) pandemic

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality

Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsyconfirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects

Risk of myocardial infarction and stroke after acute infection or vaccination

COVID-19 and the heart

Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic

Considerations for cardiac Catherization laboratory procedures during the COVID-19 pandemic. Perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) members and graduates

The evolving pandemic of COVID-19 and interventional cardiology

Spontaneous coronary artery dissection in a patient with COVID-19